Latest News
Court Rules to Reinstate Significant Restrictions on Abortion Medication but Not to Revoke FDA Approval of the Drug
Mifepristone will remain available under current regulations due to an earlier U.S. Supreme Court order.
The Center and Partners Sue South Carolina to Block New Abortion Ban
A six-week abortion ban—nearly identical to one thrown out by the state supreme court earlier this year—was signed into law this morning, causing chaos and confusion for patients and providers.
New Report Shows More Evidence of Harm Caused by Abortion Bans
Report by ANSIRH details poor-quality care post-Roe and its harm to patients and providers.
New Study Finds Many Refugees from Ukraine are Cut Off from Reproductive Health Care
Facing restrictive abortion and contraception laws and other quality of care barriers in Poland, Hungary, Romania and Slovakia, many women feel they have no choice but to return to Ukraine to obtain care.
Center Files Lawsuit to Ensure Access to Abortion Drug in Three States
Lawsuit seeks to protect mifepristone access in Virginia, Montana, and Kansas in light of the drug’s legal uncertainty.
Health, Pharmaceutical and Legal Experts Urge Circuit Court to Reverse Order Attempting to Block FDA’s Approval of Abortion Drug
Case to be argued at the Fifth Circuit Court of Appeals on May 17.
Medicaid Rule Limiting Abortion Access in Montana Is Blocked After Lawsuit by the Center and Partners
New state rule would have effectively eliminated access to abortion care for most Montanans insured through Medicaid.
Plaintiff in Center’s Case Against Texas to Testify at the U.S. Senate April 26
Amanda Zurawski to testify at the Senate Judiciary Committee hearing on "The Assault on Reproductive Rights in a Post-Dobbs America." Watch the hearing live.
Reproductive rights are human rights.
Help us ensure that every government around the world guarantees them.
New Study Finds Oklahoma Hospitals Unable to Provide Clear and Accurate Information on Emergency Obstetric Care
Report by the Center, Physicians for Human Rights, and Oklahoma Call for Reproductive Justice raises concerns about pregnant patients’ ability to access life-saving obstetric care in states where abortion is banned.
“Let’s Talk Repro” Series: Breana Lipscomb, Senior Advisor for Maternal Health & Rights
“Movements for change are most impactful when the communities that are most affected by human rights violations are leading on that change.”
The Center and Movement Partners Urge Court to Block Unprecedented Ruling Rejecting FDA’s Approval of Abortion Drug
Amicus brief of more than 100 reproductive rights, health, and justice partners highlights the proven safety and efficacy of the drug, the ruling’s “immediate and life-threatening consequences,” and the court’s reliance on “debunked data.”
Texas Court’s Radical Decision Attempts to Block FDA Approval of a Medication Abortion Drug Used for More Than 20 Years
Ruling is a devastating blow to abortion access across the U.S.
Black Maternal Health Week, April 11-17
Amidst an alarming rise in maternal mortality in the U.S., the week aims to raise awareness around racial inequities in maternal health outcomes.
Reproductive rights are human rights.
Help us ensure that every government around the world guarantees them.